Crestchem

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE293N01016
  • NSEID:
  • BSEID: 526269
INR
92.79
-0.21 (-0.23%)
BSENSE

Mar 06

BSE+NSE Vol: 164

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

164 (51.29%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

0.13%

Held by 0 DIIs

Promoter

29.94%

Has Crestchem declared dividend?

06-Jun-2025

Crestchem Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of August 23, 2024. The dividend yield is 0.3%, and while the company has shown significant price appreciation over the years, the total returns vary across different periods.

Crestchem Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 23 Aug 24<BR><BR>Dividend Yield: 0.3%.<BR><BR>Total Returns by Period:<BR>Over the 6-month period, Crestchem experienced a price return of -39.7%, with no dividend return, resulting in a total return of -39.7%.<BR><BR>In the 1-year period, the price return was 26.84%, with a dividend return of 0.37%, leading to a total return of 27.21%.<BR><BR>For the 2-year period, the price return was 84.46%, with a dividend return of 0.68%, resulting in a total return of 85.14%.<BR><BR>During the 3-year period, the price return was 243.46%, with a dividend return of 1.12%, culminating in a total return of 244.58%.<BR><BR>In the 4-year period, the price return was 328.42%, with a dividend return of 1.10%, leading to a total return of 329.52%.<BR><BR>Over the 5-year period, Crestchem saw a remarkable price return of 1450.48%, with a dividend return of 4.76%, resulting in a total return of 1455.24%.<BR><BR>Overall, Crestchem has declared a dividend while also showing varying total returns over different periods, with significant growth in price returns, particularly over the longer term. The dividend yield remains relatively low compared to the substantial price appreciation.

View full answer

Who are the peers of the Crestchem?

03-Jun-2025

Crestchem's peers include Pidilite Industries, SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Hardcast & Waud, Seya Industries, Yug Decor, and Vikram Aroma. Crestchem has good management risk and growth, with a 1-year return of 31.30%, while Himadri Special leads with 41.42% return, and Seya Industries has the lowest at -22.50%.

Peers: The peers of Crestchem are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Hardcast.& Waud, Seya Industries, Yug Decor, Vikram Aroma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Deepak Nitrite, Pidilite Inds., and SRF, while Good management risk is found at Crestchem and Yug Decor. Average management risk is present at Himadri Special and Gujarat Fluoroch, and Below Average management risk is noted for Hardcast.& Waud, Seya Industries, and Vikram Aroma. Growth is Good at Crestchem and Himadri Special, Average at Pidilite Inds. and SRF, Below Average at Gujarat Fluoroch, Deepak Nitrite, Hardcast.& Waud, Seya Industries, and Vikram Aroma, and the rest have varying ratings. Capital Structure is Excellent at Pidilite Inds. and Deepak Nitrite, Good at Gujarat Fluoroch, Himadri Special, Crestchem, and Vikram Aroma, and Below Average at Seya Industries.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Himadri Special at 41.42%, while the lowest is Seya Industries at -22.50%. Crestchem's 1-year return of 31.30% is higher than Seya Industries but lower than Himadri Special. Additionally, several peers, including Deepak Nitrite, Hardcast.& Waud, Seya Industries, and Vikram Aroma, have negative six-month returns.

View full answer

What is the technical trend for Crestchem?

09-Jun-2025

As of June 2, 2025, Crestchem's technical trend has shifted to bearish, supported by a weak weekly MACD, bearish Bollinger Bands, and significant recent declines of -9.24% over one week and -15.63% over one month, despite a contrasting bullish monthly KST.

As of 2 June 2025, the technical trend for Crestchem has changed from mildly bearish to bearish. The current stance is bearish with a strong indication of weakness. The weekly MACD is bearish, and Bollinger Bands are also signaling bearish conditions. Daily moving averages confirm the bearish trend. While the monthly KST is bullish, it contrasts with the bearish signals from other indicators. The stock has seen significant declines recently, with a 1-week return of -9.24% and a 1-month return of -15.63%, further supporting the bearish outlook.

View full answer

Who are in the management team of Crestchem?

16-Jul-2025

As of March 2023, the management team of Crestchem includes Dipak N Patel (Chairman & Managing Director), Khyati Dipakkumar Vyas (CFO & Company Secretary), and several non-executive and independent directors: Rajesh I Mody, Binaben Parasbhai Patel, Nitin Shantilal Shah, and Manojkumar Babubhai Patel, along with Executive Director Nirmit Dipak Patel.

As of March 2023, the management team of Crestchem includes the following members:<BR><BR>1. Dipak N Patel - Chairman & Managing Director<BR>2. Rajesh I Mody - Non-Executive & Independent Director<BR>3. Binaben Parasbhai Patel - Non-Executive & Independent Director<BR>4. Nitin Shantilal Shah - Non-Executive & Independent Director<BR>5. Khyati Dipakkumar Vyas - CFO & Company Secretary<BR>6. Manojkumar Babubhai Patel - Independent Director<BR>7. Nirmit Dipak Patel - Executive Director<BR><BR>These individuals play key roles in the governance and management of the company.

View full answer

What does Crestchem do?

17-Jul-2025

Crestchem Ltd is a micro-cap company specializing in the processing, manufacturing, trading, and marketing of specialty chemical ingredients. As of March 2025, it reported net sales of 72 Cr and a net profit of 6 Cr.

Overview:<BR>Crestchem Ltd is engaged in the processing, manufacturing, trading, and marketing of specialty chemical ingredients, operating within the specialty chemicals industry and classified as a micro-cap company.<BR><BR>History:<BR>Crestchem Limited was incorporated in April 1991. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 72 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 6 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 50 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 19.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.30% <BR>Debt Equity: -0.10 <BR>Return on Equity: 36.50% <BR>Price to Book: 6.73 <BR><BR>Contact Details:<BR>Address: Sr No 550/1 Sub Plot No 12, Village-Indrad Taluka Kadi Mehsana Gujarat : 382715 <BR>Tel: 91-2764-278247/09409119484 <BR>Email: info@crestchemlimited.in/investor@c <BR>Website: http://www.crestchemlimited.in

View full answer

Who are the top shareholders of the Crestchem?

17-Jul-2025

The top shareholder of Crestchem is Mr. Dipak Narendraprasad Patel, with a 28.94% stake. Individual investors hold 66.63% of the shares, with no institutional holdings or pledged promoter shares.

The top shareholders of Crestchem include Mr. Dipak Narendraprasad Patel, who holds the highest promoter stake at 28.94%. Additionally, individual investors collectively hold a significant portion of the company, accounting for 66.63% of the shareholding. There are no institutional holdings from mutual funds or foreign institutional investors, and there are no pledged promoter holdings.

View full answer

How big is Crestchem?

24-Jul-2025

As of 24th July, Crestchem Ltd has a market capitalization of 49.00 Cr, with recent net sales of 25.08 Cr and a net profit of 2.73 Cr. The balance sheet for March 2024 shows shareholder's funds of 4.90 Cr and total assets of 7.13 Cr.

As of 24th July, Crestchem Ltd has a market capitalization of 49.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Crestchem reported Net Sales of 25.08 Cr and a Net Profit of 2.73 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 4.90 Cr and Total Assets of 7.13 Cr.

View full answer

When is the next results date for Crestchem?

06-Nov-2025

Crestchem is scheduled to declare its results on 12 November 2025.

Crestchem is scheduled to declare its results on 12 November 2025.

View full answer

How has been the historical performance of Crestchem?

15-Nov-2025

Crestchem has shown significant growth in net sales and profitability, with net sales increasing from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25, and profit after tax rising from 0.57 Cr to 2.73 Cr during the same period. The company's financial performance reflects strong operational efficiency and enhanced shareholder value.

Answer:<BR>The historical performance of Crestchem shows a significant upward trend in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Crestchem's net sales have increased from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25, reflecting a strong growth trajectory. The total operating income followed a similar pattern, rising from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25. The raw material costs also increased, from 5.82 Cr in Mar'21 to 18.76 Cr in Mar'25, indicating higher production expenses. Operating profit, excluding other income, improved from 0.65 Cr in Mar'21 to 3.28 Cr in Mar'25, while the overall operating profit rose from 0.70 Cr to 3.72 Cr during the same period. Profit before tax showed a notable increase from 0.67 Cr in Mar'21 to 3.66 Cr in Mar'25, leading to a profit after tax of 2.73 Cr in Mar'25, up from 0.57 Cr in Mar'21. The earnings per share also grew significantly from 1.9 in Mar'21 to 9.1 in Mar'25. On the balance sheet, total assets increased from 3.00 Cr in Mar'21 to 10.52 Cr in Mar'25, while total liabilities rose from 3.00 Cr to 10.52 Cr, with no long-term borrowings reported. The book value per share improved from 4.97 in Mar'21 to 24.92 in Mar'25, indicating enhanced shareholder value. Cash flow from operating activities turned positive in Mar'24 at 1.00 Cr and remained steady in Mar'25, showcasing improved operational efficiency. Overall, Crestchem's financial performance demonstrates robust growth and profitability over the years.

View full answer

Is Crestchem overvalued or undervalued?

20-Nov-2025

As of November 19, 2025, Crestchem is fairly valued with a PE ratio of 17.38 and has underperformed the Sensex with a year-to-date return of -58.22%, making it less attractive compared to peers like Godrej Industries and Solar Industries.

As of 19 November 2025, Crestchem's valuation grade has moved from very attractive to fair, indicating a shift in its market perception. The company is currently fairly valued, with a PE ratio of 17.38, an EV to EBITDA of 15.34, and a ROE of 25.03%. In comparison, peers such as Godrej Industries, which is rated attractive, has a significantly higher PE ratio of 37.28, while Solar Industries is deemed very expensive with a PE of 94.38.<BR><BR>Despite the fair valuation, Crestchem has underperformed relative to the Sensex, with a year-to-date return of -58.22% compared to the Sensex's 9.02%. This underperformance, coupled with its current ratios, suggests that while Crestchem may not be undervalued, it is not positioned as a strong investment compared to its peers in the specialty chemicals sector.

View full answer

Are Crestchem Ltd latest results good or bad?

14-Feb-2026

Crestchem Ltd's latest results show strong revenue and profit growth, with a net profit increase of 33.33% quarter-on-quarter. However, concerns about declining operating margins and bearish market trends suggest caution for investors.

Crestchem Ltd's latest results present a mixed picture. On the positive side, the company reported a net profit of ₹0.72 crore for Q3 FY26, which is a significant increase of 33.33% quarter-on-quarter and 38.46% year-on-year. Additionally, revenue saw a substantial year-on-year growth of 49.17%, reaching ₹7.16 crore, although it experienced a slight decline of 0.42% compared to the previous quarter.<BR><BR>However, there are notable concerns regarding the company's operating margins, which have compressed significantly. The operating margin, excluding other income, fell to 11.31%, down from 13.54% in the same quarter last year, indicating rising cost pressures in the specialty chemicals sector. This margin compression raises questions about the sustainability of profit growth, as the increase in profits seems to be driven more by revenue expansion rather than operational efficiency.<BR><BR>Furthermore, the company's return on equity remains strong at 32.76%, reflecting effective capital utilization, but the overall financial performance is tempered by the bearish technical trends and a proprietary score that places it in "Strong Sell" territory.<BR><BR>In summary, while Crestchem has shown impressive revenue and profit growth, the deterioration in operating margins and the broader market performance suggest caution. Investors should closely monitor future results to assess whether the company can stabilize its margins and maintain its growth trajectory.

View full answer

Should I buy, sell or hold Crestchem Ltd?

15-Feb-2026

Why is Crestchem Ltd falling/rising?

04-Mar-2026

As of 04-Mar, Crestchem Ltd's stock price is at 89.31, down 2.46%, and has underperformed its sector. The stock is in a bearish trend, trading below all key moving averages, with significant declines in both short-term and long-term performance.

As of 04-Mar, Crestchem Ltd's stock price is falling, currently at 89.31, which reflects a decrease of 2.25 or 2.46%. The stock has underperformed its sector by 1.93% today and has been on a consecutive decline for the last two days, resulting in a total drop of 3.5% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>Investor participation has also decreased significantly, with delivery volume dropping by 72.59% compared to the 5-day average, suggesting reduced interest from investors. The stock's performance over various time frames shows a year-to-date decline of 20.58% and a staggering 54.43% drop over the past year, contrasting sharply with the Sensex, which has gained 8.39% in the same period. These factors collectively contribute to the ongoing decline in Crestchem Ltd's stock price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Flat results in Dec 25

  • ROCE(HY) Lowest at 32.96%
2

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

INR 28 Cr (Micro Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

39

stock-summary
Dividend Yield

1.08%

stock-summary
Debt Equity

-0.13

stock-summary
Return on Equity

27.51%

stock-summary
Price to Book

3.46

Revenue and Profits:
Net Sales:
7 Cr
(Quarterly Results - Dec 2025)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.08%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-23.66%
0%
-23.66%
6 Months
-22.67%
0%
-22.67%
1 Year
-57.05%
0.41%
-56.64%
2 Years
-29.46%
1.20%
-28.26%
3 Years
16.22%
1.34%
17.56%
4 Years
139.46%
3.42%
142.88%
5 Years
213.48%
5.45%
218.93%

Latest dividend: 1 per share ex-dividend date: Aug-13-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Press Release / Media Release

16-Feb-2026 | Source : BSE

Dear Sir PRESS RELEASE LOK MITRA ( GUJARATI) FREE PRESS GUJARAT ( ENGLISH) PUBLISHED ON 16/02/2026

Escrow Payment Mechanism

14-Feb-2026 | Source : BSE

Dear Sir Escrow Payment Mechanism is not applicable to our Company. Nitin S.Shah Company Secretary & Compliance Officer ACS-7088

Board Meeting Outcome for Unaudited Financial Results 31-12-2025

13-Feb-2026 | Source : BSE

Unaudited Financial Results 31-12-2025

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Crestchem Ltd has declared 10% dividend, ex-date: 13 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
29.17%
EBIT Growth (5y)
22.69%
EBIT to Interest (avg)
1.91
Debt to EBITDA (avg)
0.34
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
4.19
Tax Ratio
23.71%
Dividend Payout Ratio
11.00%
Pledged Shares
0
Institutional Holding
0.13%
ROCE (avg)
49.58%
ROE (avg)
32.76%

Valuation key factors

Factor
Value
P/E Ratio
13
Industry P/E
39
Price to Book Value
3.46
EV to EBIT
11.67
EV to EBITDA
11.28
EV to Capital Employed
3.82
EV to Sales
1.01
PEG Ratio
NA
Dividend Yield
1.08%
ROCE (Latest)
30.63%
ROE (Latest)
27.51%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Mr. Dipak Narendraprasad Patel (29.2%)

Highest Public shareholder

None

Individual Investors Holdings

65.99%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -0.42% vs 42.94% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 33.33% vs 54.29% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.16",
          "val2": "7.19",
          "chgp": "-0.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.81",
          "val2": "0.61",
          "chgp": "32.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.72",
          "val2": "0.54",
          "chgp": "33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.31%",
          "val2": "8.48%",
          "chgp": "2.83%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -6.36% vs 57.80% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -44.03% vs 178.95% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.22",
          "val2": "13.05",
          "chgp": "-6.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.97",
          "val2": "2.03",
          "chgp": "-52.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.01",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.89",
          "val2": "1.59",
          "chgp": "-44.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.94%",
          "val2": "15.56%",
          "chgp": "-7.62%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 8.57% vs 14.20% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -23.70% vs 42.57% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.38",
          "val2": "17.85",
          "chgp": "8.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.78",
          "val2": "2.68",
          "chgp": "-33.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.01",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.61",
          "val2": "2.11",
          "chgp": "-23.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.18%",
          "val2": "15.01%",
          "chgp": "-5.83%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 17.97% vs 27.08% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 26.98% vs 211.59% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.08",
          "val2": "21.26",
          "chgp": "17.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.28",
          "val2": "2.78",
          "chgp": "17.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.01",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.73",
          "val2": "2.15",
          "chgp": "26.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.08%",
          "val2": "13.08%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
7.16
7.19
-0.42%
Operating Profit (PBDIT) excl Other Income
0.81
0.61
32.79%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.72
0.54
33.33%
Operating Profit Margin (Excl OI)
11.31%
8.48%
2.83%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -0.42% vs 42.94% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 33.33% vs 54.29% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
12.22
13.05
-6.36%
Operating Profit (PBDIT) excl Other Income
0.97
2.03
-52.22%
Interest
0.00
0.01
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.89
1.59
-44.03%
Operating Profit Margin (Excl OI)
7.94%
15.56%
-7.62%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -6.36% vs 57.80% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -44.03% vs 178.95% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
19.38
17.85
8.57%
Operating Profit (PBDIT) excl Other Income
1.78
2.68
-33.58%
Interest
0.00
0.01
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.61
2.11
-23.70%
Operating Profit Margin (Excl OI)
9.18%
15.01%
-5.83%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 8.57% vs 14.20% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -23.70% vs 42.57% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
25.08
21.26
17.97%
Operating Profit (PBDIT) excl Other Income
3.28
2.78
17.99%
Interest
0.01
0.01
Exceptional Items
0.00
0.00
Standalone Net Profit
2.73
2.15
26.98%
Operating Profit Margin (Excl OI)
13.08%
13.08%
NA
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 17.97% vs 27.08% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 26.98% vs 211.59% in Mar 2024

stock-summaryCompany CV
About Crestchem Ltd stock-summary
stock-summary
Crestchem Ltd
Micro Cap
Specialty Chemicals
Crestchem Limited was incorporated in April, 1991. The Company is engaged in the field of processing / manufacturing/trading and marketing, of specialty chemical ingredients, the Companies products Caprylic / Capric Triglycerides in oil form and powder form and its down steam products also finds uses in Industrial fields and such other uses.
Company Coordinates stock-summary
Company Details
Sr No 550/1 Sub Plot No 12, Village-Indrad Taluka Kadi Mehsana Gujarat : 382715
stock-summary
Tel: 91-2764-278247/09409119484
stock-summary
info@crestchemlimited.in/investor@c
Registrar Details